Profile
Mr. Mark Evans is a Chairman at Obotritia Capital KGaA. Mr. Evans was previously employed as a Non-Independent Non-Executive Director by ReNeuron Group Plc, a Partner by Taube Hodson Stonex Partners LLP, and a Partner by Albemarle Life Sciences LLP.
He received his undergraduate degree from the University of Bristol.
Mark Evans active positions
| Companies | Position | Start |
|---|---|---|
Obotritia Capital KGaA
Obotritia Capital KGaA Investment ManagersFinance Obotritia Capital invests in both public and private companies located in Germany. The firm focuses on real estate, financial services and technology. It participates in early stage transactions and also acquires majority interests. | Chairman | - |
Former positions of Mark Evans
| Companies | Position | End |
|---|---|---|
| RENEURON GROUP PLC | Director/Board Member | 2022-03-21 |
Taube Hodson Stonex Partners LLP
Taube Hodson Stonex Partners LLP Investment ManagersFinance Provides investment advice | Corporate Officer/Principal | 2015-12-31 |
Albemarle Life Sciences LLP
Albemarle Life Sciences LLP MiscellaneousMiscellaneous Operates as a non classified establishment | Corporate Officer/Principal | - |
Training of Mark Evans
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
ReNeuron Group Plc
ReNeuron Group Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and manufactures cell-based therapy products | Health Technology |
Taube Hodson Stonex Partners LLP
Taube Hodson Stonex Partners LLP Investment ManagersFinance Provides investment advice | Finance |
University of Bristol
University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Obotritia Capital KGaA
Obotritia Capital KGaA Investment ManagersFinance Obotritia Capital invests in both public and private companies located in Germany. The firm focuses on real estate, financial services and technology. It participates in early stage transactions and also acquires majority interests. | Finance |
Albemarle Life Sciences LLP
Albemarle Life Sciences LLP MiscellaneousMiscellaneous Operates as a non classified establishment | Miscellaneous |
- Stock Market
- Insiders
- Mark Evans
















